U.S. Health Care Enforcement: Priorities and Key Regulatory Developments Webinar

Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.

Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.

Get the latest on new policy updates and guidance for the clinical evaluation of medical devices.

Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease.

Join us in Washington, D.C. for our Cybersecurity Summit that will address the future of medical device cybersecurity and changes in the industry landscape related to FDA requirements.

Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.

The AdvaMed Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed China Code” or “Code” – serves as a foundational charter for medical technology companies’ compliance programs and encourages the companies to adopt best practices in the ethics unique to their industry.